302 related articles for article (PubMed ID: 7261976)
21. Therapeutic aspects of hyperlipidaemia in diabetes.
Durrington PN; Winocour PH
Postgrad Med J; 1989; 65 Suppl 1():S33-41. PubMed ID: 2695908
[No Abstract] [Full Text] [Related]
22. [Are PPAR-gamma-agonists a secure choice in treatment of overweight diabetic patients?].
Larsen PJ
Ugeskr Laeger; 2000 Aug; 162(32):4280-1. PubMed ID: 10962950
[No Abstract] [Full Text] [Related]
23. Cardiovascular effects of insulin sensitizers in diabetes.
Jawa A; Fonseca V
Curr Opin Investig Drugs; 2006 Sep; 7(9):806-14. PubMed ID: 17002258
[TBL] [Abstract][Full Text] [Related]
24. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
[TBL] [Abstract][Full Text] [Related]
25. [New drugs for diabetes treatment. Fast-acting insulin analogues].
Forst T
Pharm Unserer Zeit; 2001; 30(2):118-23. PubMed ID: 11279981
[No Abstract] [Full Text] [Related]
26. Are you up to date on diabetes medications?
Kestel F
Am J Nurs; 1994 Jul; 94(7):48-52. PubMed ID: 8017497
[No Abstract] [Full Text] [Related]
27. Secondary failure to oral hypoglycaemic therapy in diabetes.
Ennis G
Aust Fam Physician; 1976 Sep; 5(8):1147-9. PubMed ID: 1088880
[No Abstract] [Full Text] [Related]
28. [Pharmacological sheet. Vildagliptin, oral administration (GALVUS)].
J Pharm Belg; 2009 Jun; (2):64-6. PubMed ID: 19739530
[No Abstract] [Full Text] [Related]
29. Diabetic angiopathy and sulfonylurea therapy.
Balodimos MC; Marble A
Minn Med; 1968 Oct; 51(10):1341-4. PubMed ID: 5697884
[No Abstract] [Full Text] [Related]
30. Management of the elderly diabetic patient.
Shetty KR
Wis Med J; 1982 Aug; 81(8):40-2. PubMed ID: 6753352
[No Abstract] [Full Text] [Related]
31. The treatment of diabetes. 3. Insulin and oral hypoglycaemic drugs.
Ormerod TP; Stones P
Nurs Times; 1969 Jun; 65(24):750-2. PubMed ID: 5803411
[No Abstract] [Full Text] [Related]
32. Oral hypoglycaemic drugs.
O'Sullivan DJ
Ir Med J; 1982 Jun; 75(6):178-82. PubMed ID: 7107183
[No Abstract] [Full Text] [Related]
33. On the treatment of diabetes with Adebit.
Geiger E; Fiala E; Révész A; Vedres K
Ther Hung; 1970; 18(4):171-4. PubMed ID: 5514492
[No Abstract] [Full Text] [Related]
34. Value of tolazamide "'Tolanase') as an oral hypoglycaemic agent.
Tewari SN; Fletcher R
Br J Clin Pract; 1967 Sep; 21(9):455-6. PubMed ID: 4864489
[No Abstract] [Full Text] [Related]
35. Comparison of glibenclamide with other oral hypoglycaemic agents.
Wetherill JH; Tunbridge RE
Postgrad Med J; 1970 Dec; ():Suppl:88-91. PubMed ID: 5533304
[No Abstract] [Full Text] [Related]
36. [Our experiences with silubin R].
Berović R; Slijepcević D; Bozović B
Srp Arh Celok Lek; 1967 Oct; 95(10):889-98. PubMed ID: 5598678
[No Abstract] [Full Text] [Related]
37. Study: tight glucose control in diabetes lowers risk of atherosclerosis.
FDA Consum; 2003; 37(4):10. PubMed ID: 12971340
[No Abstract] [Full Text] [Related]
38. [Pharmacology and therapeutics: oral antidiabetic agents - usage and current trends].
Beltrán Lendinez M; Parras Puche M; Liebanas Pegalajar C; García Jiménez JA
Rev Enferm; 1982 Feb; 5(44):13-8. PubMed ID: 7041228
[No Abstract] [Full Text] [Related]
39. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus].
Beliaeva NF; Gorodetskiĭ VK; Tochilkin AI; Golubev MA; Semenova NV; Kovel'man IR
Vopr Med Khim; 2000; 46(4):344-60. PubMed ID: 11075417
[TBL] [Abstract][Full Text] [Related]
40. The Unitarian Hypothesis for the aetiology of diabetes mellitus.
Morrison EY; Ragoobirsingh D; Peter SA
Med Hypotheses; 2006; 67(5):1115-20. PubMed ID: 16806731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
